2079 related articles for article (PubMed ID: 25953352)
1. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
2. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
3. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
4. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
6. More specific CRISPR editing.
de Souza N
Nat Methods; 2014 Jul; 11(7):712. PubMed ID: 25110782
[No Abstract] [Full Text] [Related]
7. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
9. Development of CRISPR/Cas9 mediated virus resistance in agriculturally important crops.
Khatodia S; Bhatotia K; Tuteja N
Bioengineered; 2017 May; 8(3):274-279. PubMed ID: 28581909
[TBL] [Abstract][Full Text] [Related]
10. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
12. Efficient Screening of CRISPR/Cas9-Induced Events in Drosophila Using a Co-CRISPR Strategy.
Kane NS; Vora M; Varre KJ; Padgett RW
G3 (Bethesda); 2017 Jan; 7(1):87-93. PubMed ID: 27793971
[TBL] [Abstract][Full Text] [Related]
13. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
Chakraborty C; Teoh SL; Das S
Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
[TBL] [Abstract][Full Text] [Related]
14. The application of CRISPR/Cas9 in genome editing of filamentous fungi.
Li HH; Liu G
Yi Chuan; 2017 May; 39(5):355-367. PubMed ID: 28487268
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed conditional genome editing with Cas12a in
Port F; Starostecka M; Boutros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
[TBL] [Abstract][Full Text] [Related]
16. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
Shen B; Brown K; Long S; Sibley LD
Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
[TBL] [Abstract][Full Text] [Related]
17. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
18. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
Song M
Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
[TBL] [Abstract][Full Text] [Related]
19. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
20. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
